Healthcare costs in psoriasis and psoriasis sub-groups over time following psoriasis diagnosis (English)
Free access
- New search for: Al Sawah, Sarah
- New search for: Foster, Shonda A.
- New search for: Goldblum, Orin M.
- New search for: Malatestinic, William N.
- New search for: Zhu, Baojin
- New search for: Shi, Nianwen
- New search for: Song, Xue
- New search for: Feldman, Steven R.
- New search for: Al Sawah, Sarah
- New search for: Foster, Shonda A.
- New search for: Goldblum, Orin M.
- New search for: Malatestinic, William N.
- New search for: Zhu, Baojin
- New search for: Shi, Nianwen
- New search for: Song, Xue
- New search for: Feldman, Steven R.
In:
Journal of Medical Economics
;
20
, 9
;
982-990
;
2017
- Article (Journal) / Electronic Resource
-
Title:Healthcare costs in psoriasis and psoriasis sub-groups over time following psoriasis diagnosis
-
Contributors:Al Sawah, Sarah ( author ) / Foster, Shonda A. ( author ) / Goldblum, Orin M. ( author ) / Malatestinic, William N. ( author ) / Zhu, Baojin ( author ) / Shi, Nianwen ( author ) / Song, Xue ( author ) / Feldman, Steven R. ( author )
-
Published in:Journal of Medical Economics ; 20, 9 ; 982-990
-
Publisher:
- New search for: Taylor & Francis
-
Publication date:2017-09-02
-
Size:9 pages
-
ISSN:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:English
-
Keywords:
-
Source:
Table of contents – Volume 20, Issue 9
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 903
-
The effects of global budget on cost control and readmission in rural China: a difference-in-difference analysisHe, Ruibo / Miao, Yudong / Ye, Ting / Zhang, Yan / Tang, Wenxi / Li, Zhong / Zhang, Liang et al. | 2017
- 911
-
Cost-effectiveness of blinatumomab versus salvage chemotherapy in relapsed or refractory Philadelphia-chromosome-negative B-precursor acute lymphoblastic leukemia from a US payer perspectiveDelea, Thomas E. / Amdahl, Jordan / Boyko, Diana / Hagiwara, May / Zimmerman, Zachary F. / Franklin, Janet L. / Cong, Ze / Hechmati, Guy / Stein, Anthony et al. | 2017
- 923
-
Expert panel on practice patterns in the management of cow’s milk protein allergy and associated economic burden of disease on health service in TurkeySekerel, Bulent Enis / Seyhun, Oznur et al. | 2017
- 931
-
Methods for estimating costs in patients with hyperlipidemia experiencing their first cardiovascular event in the United KingdomDanese, Mark D. / Gleeson, Michelle / Griffiths, Robert I. / Catterick, David / Kutikova, Lucie et al. | 2017
- 938
-
Examining the association of smoking with work productivity and associated costs in JapanSuwa, Kiyomi / Flores, Natalia M. / Yoshikawa, Reiko / Goto, Rei / Vietri, Jeffrey / Igarashi, Ataru et al. | 2017
- 945
-
Cost reduction from resolution/improvement of carcinoid syndrome symptoms following treatment with above-standard dose of octreotide LARHuynh, Lynn / Totev, Todor / Vekeman, Francis / Neary, Maureen P. / Duh, Mei S. / Benson, Al B. et al. | 2017
- 952
-
Major bleeding risk and healthcare economic outcomes of non-valvular atrial fibrillation patients newly-initiated with oral anticoagulant therapy in the real-world settingLin, Jay / Trocio, Jeffrey / Gupta, Kiran / Mardekian, Jack / Lingohr-Smith, Melissa / Menges, Brandy / You, Min / Nadkarni, Anagha et al. | 2017
- 962
-
Costs and effectiveness of fingolimod versus alemtuzumab in the treatment of highly active relapsing-remitting multiple sclerosis in the UK: re-treatment, discount, and disutilityMontgomery, Stephen M. / Kusel, Jeanette / Nicholas, Richard / Adlard, Nicholas et al. | 2017
- 974
-
Real-life cost of vitamin K antagonist treatment in patients with non-valvular atrial fibrillation in France in 2013Dallongeville, Jean / Ansolabehere, Xavier / Karusisi, Noëlla / Maurel, Frédérique / Van Ganse, Eric / Le Heuzey, Jean-Yves et al. | 2017
- 982
-
Healthcare costs in psoriasis and psoriasis sub-groups over time following psoriasis diagnosisAl Sawah, Sarah / Foster, Shonda A. / Goldblum, Orin M. / Malatestinic, William N. / Zhu, Baojin / Shi, Nianwen / Song, Xue / Feldman, Steven R. et al. | 2017
- 991
-
Cost-effectiveness of insulin detemir versus insulin glargine for Thai type 2 diabetes from a payer’s perspectivePermsuwan, Unchalee / Thavorn, Kednapa / Dilokthornsakul, Piyameth / Saokaew, Surasak / Chaiyakunapruk, Nathorn et al. | 2017
- 1000
-
Budget impact model in moderate-to-severe psoriasis vulgaris assessing effects of calcipotriene and betamethasone dipropionate foam on per-patient standard of care costsAsche, Carl V. / Kim, Minchul / Feldman, Steven R. / Zografos, Panagiotis / Lu, Minyi et al. | 2017
- 1007
-
Evaluation of healthcare resource utilization and incremental economic burden of patients with chronic myeloid leukemia after disease progression to blast phaseJabbour, Elias J. / Lin, Jay / Siegartel, Lisa R. / Lingohr-Smith, Melissa / Menges, Brandy / Makenbaeva, Dinara et al. | 2017